TY  - JOUR
T1  - Helical tomotherapy based intensity modulated radiotherapy for the management of difficult clinical situations in breast cancer
A1  - Animesh Saha
A1  - Anurupa Mahata
A1  - Rajkumar Shrimali
A1  - Rimpa Achari
A1  - Indranil Mallick
A1  - Sanjoy Chatterjee
JF  - Clinical Cancer Investigation Journal
JO  - Clin Cancer Investig J
SN  - 2278-0513
Y1  - 2015
VL  - 4
IS  - 4
DO  - 10.4103/2278-0513.159788
SP  - 543
EP  - 547
N2  - Helical tomotherapy (HT) can achieve a homogenous dose distribution in the planning target volume while minimizing the dose to the organ at risk. Tomotherapy has been used for complex breast cancer radiotherapy including bilateral breast irradiation, pectus excavatum, and internal mammary chain (IMC) nodal irradiation. This report details our experience of using HT in breast cancers in newer clinical indications. Three patients with SCF nodal involvement (case 1), high level III axillary node recurrence (case 2), and composite irradiation of SCF, IMC, and whole breast (case 3) were treated using brachial plexus sparing HT. It was possible to boost the SCF, reirradiate the high level III axillary nodal recurrence and treat complex volume of breast, SCF, and IMC with acceptable and safe dose volume histogram constraints and with good homogeneity and conformity indices. The treatment was successful in controlling disease locoregionally at a 15 months follow-up. No patients reported symptoms suggestive of brachial plexopathy
UR  - https://ccij-online.org/article/helical-tomotherapy-based-intensity-modulated-radiotherapy-for-the-management-of-difficult-clinical-situations-in-breast-cancer-446
ER  -